Ximelagatran versus warfarin: A comparison of bleeding outcomes in patients with nonvalvular atrial fibrillation

被引：0
|
作者：
Douketis, JD
Arneklev, K
Goldhaber, S
Spandorfer, J
Halperin, F
Horrow, J
机构：
[1] McMaster Univ, Hamilton, ON, Canada
[2] AstraZeneca R&D Molndal, Biostat, Molndal, Sweden
[3] Brigham & Womens Hosp, Boston, MA 02115 USA
[4] Thomas Jefferson Univ, Jefferson Med Coll, Philadelphia, PA 19107 USA
[5] Kelowna Gen Hosp, Kelowna, BC, Canada
[6] AstraZeneca LP, Wilmington, DE USA
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
10.1182/blood.V104.11.1765.1765
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1765
引用
收藏
页码：489A / 489A
页数：1
相关论文
共 50 条
  • [1] Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation - A Randomized trial
    Albers, GW
    Diener, HC
    Frison, L
    Grind, M
    Nevinson, M
    Partridge, S
    Halperin, JL
    Horrow, J
    Olsson, SB
    Petersen, P
    Vahanian, A
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (06): : 690 - 698
  • [2] The Comparison of Therapeutic Efficacy Between Dabigatran Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation
    Li, Hongxia
    Zhang, Lei
    Xia, Ming
    Zhang, Chi
    Jiang, Tingbo
    [J]. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2021, 27
  • [3] Comparison of bleeding in patients with nonvalvular atrial fibrillation treated with ximelagatran or warfarin - Assessment of incidence, case-fatality rate, time course and sites of bleeding, and risk factors for bleeding
    Douketis, JD
    Arneklev, K
    Goldhaber, SZ
    Spandorfer, J
    Halperin, F
    Horrow, J
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2006, 166 (08) : 853 - 859
  • [4] Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
    Patel, Manesh R.
    Mahaffey, Kenneth W.
    Garg, Jyotsna
    Pan, Guohua
    Singer, Daniel E.
    Hacke, Werner
    Breithardt, Guenter
    Halperin, Jonathan L.
    Hankey, Graeme J.
    Piccini, Jonathan P.
    Becker, Richard C.
    Nessel, Christopher C.
    Paolini, John F.
    Berkowitz, Scott D.
    Fox, Keith A. A.
    Califf, Robert M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (10): : 883 - 891
  • [5] Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
    Pearson, Scott
    Troughton, Richard
    Richards, A. Mark
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (24): : 2334 - 2335
  • [6] Ximelagatran or warfarin in atrial fibrillation?
    Eikelboom, J
    Hankey, G
    [J]. LANCET, 2004, 363 (9410): : 734 - 734
  • [7] RIVAROXABAN VERSUS WARFARIN IN AFRICAN AMERICAN PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION
    Coleman, Craig I.
    Thompson, Stanley
    Ashton, Veronica
    Palladino, Michael
    Bunz, Thomas
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 338 - 338
  • [8] Rivaroxaban Versus Warfarin in African American Patients with Nonvalvular Atrial Fibrillation
    Coleman, Craig, I
    Thompson, Stanley
    Ashton, Veronica
    Palladino, Michael
    Bunz, Thomas J.
    [J]. JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2020, 112 (04) : 395 - 401
  • [9] Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation REPLY
    Patel, Manesh R.
    Fox, Keith A. A.
    Califf, Robert M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (24): : 2335 - 2335
  • [10] Ximelagatran to prevent stroke in nonvalvular atrial fibrillation
    Slawson, D
    [J]. AMERICAN FAMILY PHYSICIAN, 2005, 71 (11) : 2178 - +
12345